Table 1.

Target size and previous clinical prescription for the 9 patients included in this SRS study comparison.

Patient	Tumor location	Tumor volume (cc)	Previous Clinical prescription dose and fraction
#1	deep central region	1.66	21Gy/1f
#2	peripheral region	3.53	21Gy/1f
#3	peripheral region	14.65	15Gy/1f
#4	peripheral region	4.13	18Gy/1f
#5	peripheral region	8.34	18Gy/1f
#6	deep central region	11.04	15Gy/1f
#7	deep central region	20.76	24Gy/3f
#8	peripheral region	24.70	15Gy/1f
#9	deep central	28.65	21Gy/3f